Clinical trial
Pilot Study of Mepolizumab in Episodic Angioedema With Eosinophilia
NCT04128371 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Mepolizumab in Episodic Angioedema With Eosinophilia
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 14, 2021
- Completion date
- October 31, 2022
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.